{"id":"medibazine","rwe":[{"pmid":"37899967","year":"2023","title":"Drug repurposing by in silico prediction of cyclizine derivatives as antihyperlipemic agents.","finding":"","journal":"In silico pharmacology","studyType":"Clinical Study"},{"pmid":"158405","year":"1979","title":"[Cardiac anti-arrhythmic effect of various N-substituted piperazine derivatives with respect to aconitine in the rat].","finding":"","journal":"Comptes rendus des seances de la Societe de biologie et de ses filiales","studyType":"Clinical Study"}],"tags":[{"label":"medibazine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["medibazine"],"offLabel":[],"synonyms":["medibazine"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"medibazine","explanation":"Imagine your body's cells have locks on them, and medibazine is a key that fits into those locks. When it binds to the lock, it triggers a response that helps to treat a particular condition. However, the exact lock that medibazine binds to and how it triggers this response is not yet fully understood.","oneSentence":"Medibazine works by interacting with a specific target in the body to produce a therapeutic effect.","technicalDetail":"Medibazine is a small molecule that binds to a specific protein target, modulating its activity to produce a therapeutic effect. The exact mechanism of action is unknown, but it is thought to involve the inhibition of a particular enzyme or receptor."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3768","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MEDIBAZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:31:56.660265","biosimilars":[],"competitors":[],"genericName":"medibazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"7NFK89B690","INN_ID":"1977","UMLSCUI":"C0608093","ChEMBL_ID":"CHEMBL2104758","PUBCHEM_CID":"30974","MESH_SUPPLEMENTAL_RECORD_UI":"C019000"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2023","pmid":"37899967","title":"Drug repurposing by in silico prediction of cyclizine derivatives as antihyperlipemic agents.","journal":"In silico pharmacology"},{"date":"1979","pmid":"158405","title":"[Cardiac anti-arrhythmic effect of various N-substituted piperazine derivatives with respect to aconitine in the rat].","journal":"Comptes rendus des seances de la Societe de biologie et de ses filiales"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"MEDIBAZINE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MEDIBAZINE is a small molecule with synonyms including MEDIBAZINA, MEDIBAZINE, S-4105, and S4105.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}